,18,19,20,21,22,23,24,25,26,27 We therefore used INCERTS to identify KRAS-reactive TCRs from individuals with pancreatic or colorectal cancer who were immunized with a mutant KRAS peptide vaccine (ClinicalTrials.gov: NCT04117087). Here, KRAS is linked to colorectal cancer.